Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Neuroscience Reaches A New Inflection Point, Big Biotechs Say

Jan 25 2017

• By Jessica Merrill

High quality 3d render of nerve cells, concept for Neurologic Diseases, tumors and brain surgery.

Related Content

Celgene Sets Sights On Becoming Inflammation and Immunology Power Player

Jul 20 2015

ECTRIMS 2016: Biogen Makes Headway in MS Remyelination Studies

Sep 20 2016

Biogen CEO Pick Vounatsos Suggests A Return To Commercial Focus

Dec 20 2016

Biogen/Ionis’s Spinraza Approved; Second Antisense Drug For Neurodegeneration In 2016

Dec 28 2016

Related Companies

Biogen, Inc.

Bristol Myers Squibb Company

Ionis Pharmaceuticals, Inc.

Receptos, Inc.

Pfizer Inc.

Abide Therapeutics Inc.

Merck & Co., Inc.

Eli Lilly and Company

Additional Topics

Research & Development Neurology Inflammation BioPharmaceutical

More from Neurological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window